This is an OZY Special Briefing, an extension of the Presidential Daily Brief. The Special Briefing tells you what you need to know about an important issue, individual or story that is making news. Each one serves up an interesting selection of facts, opinions, images and videos in order to catch you up and vault you ahead. WHAT TO KNOW What’s happening. Cycling’s biggest and most famous race, the Tour de France, is back for a grueling three-week spin through the French countryside, which means that 20-bike pileups and unseen “innovations” to ride faster have returned to the sports spotlight. The 105th race was initially scheduled to begin June 30, but was pushed to July 7 so fans wouldn’t have to choose between the World Cup and the Tour. But the sport — and the race’s front-runner — is under a cloud, with industrywide doping scandals at the forefront of everyone’s mind. Why does it matter? Four-time champion Chris Froome, representing cycling supergroup Team Sky, was implicated in a doping scandal last December when he tested positive for inflated levels of the asthma medication salbutamol. ASO, the organization behind the Tour de France, banned Froome from competing — until Sunday, when cycling’s governing body cleared him of all charges. Now he’s been OK’d to join the 3,351-kilometer trek, but for French fans, who haven’t had a winner of their own nationality since 1985, Froome may seem like the second coming of Lance Armstrong in more ways than one. |